Start Leitlinien >  » KR-Karzinom >  Referenzen 
KR-Karzinom Referenzen

    Leitlinie Kolorektales Karzinom, Referenzen:


    Originaldokument der VOLLTEXTVERSION: Leitlinie der Arbeitsgemeinschaft Gastroenterologische Onkologie / Deutsche Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS)


    1.Aarnio M, Mecklin JP, Aaltonen LA, Nystrom-Lahti M, Jarvinen HJ: Lifetime risk of different cancer in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer 1995; 64: 430-3


    2.Ahlquist DA: Triage by flexible sigmoidoscopy: inevitably “short-sighted”. Gastroenterology 1998; 115: 777-80


    3.Ahsan H, Neugut AI, Garbowski GC, et al.: Family history of colorectal adenomatous polyps and increased risk for colorectal cancer. Ann Intern Med 1998; 128: 900-5


    4.Arvanitis ML, Jagelman DG, Fazio VW, Lavery IC, McGannon E: Mortality in patients with familial adenomatous polyposis. Dis Colon Rectum 1990; 33: 639


    5.Atkin WS, Morson BC, Cuzick J: Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med 1992; 326: 658-62


    6.Baron JA, Beach M, Mandel JS, et al.: Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. N Engl J Med 1999; 340: 101-7


    7.Baron JA, Sandler RS, Haile RW, Mandel JS, Mott LA, Greenberg ER: Folate intake, alcohol consumption, cigarette smoking, and risk of colorectal adenomas. J Natl Cancer Inst 1998; 90: 57-62


    8.Bensen S, Mott LA, Dain B, Rothstein R, Baron J: The colonoscopic miss rate and true one-year recurrence of colorectal neoplastic polyps. Polyp Prevention Study Group. Am J Gastroenterol 1999; 94: 194-9


    9.Binder V, Hendriksen C, Kreiner S: Prognosis in Crohn‘s disease based on results from a regional patient group from the county of Copenhagen. Gut 1985; 26: 146-50


    10.Boardman LA, Thibodeau SN, Schaid DJ, et al.: Increased risk for cancer in patients with the Peutz-Jeghers syndrome. Ann Intern Med 1998; 128: 896-9


    11.Böcker U, Katschinski B, Layer P: Colitis ulcerosa: Kein erhöhtes Risiko kolorektaler Karzinome? Z Gastroenterol 1994; 32: 184-5


    12.Bohr J, Tysk C, Eriksson S, Abrahamsson H, Jarnerot G: Collagenous colitis: a retrospective study of clincal presentation and treatment in 163 patients. Gut 1996; 39: 846-51


    13.Bonelli L, Martines H, Conio M: Family history of colorectal cancer as a risk factor for benign and malignant tumours of the large bowel. A case-control study. Int J Cancer 1988; 41: 513-7


    14.Bostick RM, Potter JD, McKenzie DR, et al.: Reduced risk of colon cancer with high intake of vitamin E: the Iowa Women‘s Health Study. Cancer Res 1993; 53: 4230-7


    15.Bülow S: Clinical features in familial polyposis coli. Results of the Danish Polyposis Register. Dis Colon Rectum 1986; 29: 102-7


    16.Burke W, Petersen G, Lynch P, et al.: Recommendations for follow-up care of individuals with inherited predisposition to cancer. JAMA 1997; 277: 915-9


    17.Choi PM, Nugent FW, Schoetz DJ, Silverman ML, Haggitt RC: Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology 1993; 105: 418-24


    18.Christie JP: Colonoscopic excision of large sessile polyps. Am J Gastroenterol 1977; 67: 430-8


    19.Clark LC, Cantor KP, Allaway WH: Selenium in forage crops and cancer mortality in US countries. Arch Environ Health 1991; 46: 37-42


    20.Coburn MC, Pricolo VE, DeLuca FG, Bland KI: Malignant potential in intestinal juvenile polyposis syndromes. Ann Surg Oncol 1995; 2: 386-91


    21.Connell WR, Talbot IC, Harpaz N, et al.: Clinicopathological characteristics of colorectal carcinoma complicating ulcerative colitis. Gut 1994; 35: 1419-23


    22.Cooper HS, Deppisch LM, Gourley WK, et al.: Endoscopically removed malignant colorectal polyps: clinicopathologic correlations. Gastroenterology 1995; 108: 1657-65


    23.Cooper HS, Deppisch LM, Kahn EI, et al.: Pathology of the malignant colorectal polyp. Hum Pathol 1998; 29: 15-26


    24.Cunningham KN, Mills LR, Schuman BM, Mwakyusa DH: Long-term prognosis of well-differentiated adenocarcinoma in endoscopically removed colorectal adenomas. Dig Dis Sci 1994; 39: 2034-7


    25.De Cosse JJ, Bülow S, Neale K, et al.: Rectal cancer risk in patients treated for familial adenomatous polyposis. The Leeds Castle Polyposis Group. Br J Surg 1992; 79: 1372-5


    26.Deutsche Krebsgesellschaft und ihre Arbeitsgemeinschaften, Deutsche Gesellschaft für Chirurgie und Deutsche Gesellschaft für Verdauungs- und Stoffwechselkrankheiten: Interdisziplinäre Leitlinie zur Therapie des Kolonkarzinoms. Forum DKG 1999; 14: 132-8


    27.Deutsche Krebsgesellschaft und ihre Arbeitsgemeinschaften, Deutsche Gesellschaft für Chirurgie und Deutsche Gesellschaft für Verdauungs- und Stoffwechselkrankheiten: Interdisziplinäre Leitlinie zur Therapie des Rektumkarzinoms. Forum DKG 1999; 14: 140-7


    28.Eckardt VF, Fuchs M, Kanzler G, Remmele W, Stienen U: Follow-up of patients with colonic polyps containing severe atypia and invasive carcinoma. Compliance, recurrence, and survival. Cancer 1988; 61: 2552-7


    29.Ekbom A, Helmick C, Zack M, Adami HO: Increased risk of large-bowel cancer in Crohn‘s disease with colonic involvement. Lancet 1990; 336: 357-9


    30.Ekbom A, Helmick CG, Zack M, Adami HO: Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 1990; 323: 1228-33


    31.Foulkes WD: A tale of four syndromes: familial adenomatous polyposis, Gardner syndrome, attenuated APC and Turcot syndrome. Q J Med 1995; 88:853-63


    32.Frühmorgen P, Kriel L: Leitlinien zur endoskopischen Ektomie kolorektaler Polypen mit der Schlinge. Z Gastroenterol 1998; 36: 117-9


    33.Fuchs CS, Giovannucci EL, Colditz GA, Hunter DJ, Speizer FE, Willett WC: A prospective study of family history and the risk of colorectal cancer. N Engl J Med 1994; 331: 1669-74


    34.Fuchs CS, Giovannuci EL, Colditz GA, et al.: Dietary fiber and the risk of colorectal cancer and adenoma in women. N Engl J Med 1999; 340: 169-76


    35.Ghadirian P, Lacroix A, Maisonneuve P, et al.: Nutritional factors and colon carcinoma: a case-control study involving French Canadians in Montreal, Quebec, Canada. Cancer 1997; 80: 858-64


    36.Giardiello FM, Welsh SB, Hamilton SR, et al.: Increased risk of cancer in the Peutz-Jeghers syndrome. N Engl J Med 1987; 316: 1511-4


    37.Gillen CD, Andrews HA, Prior P, Allan RN: Crohn‘s disease and colorectal cancer. Gut 1994; 35: 651-5


    38.Giovannucci E, Stampfer MJ, Colditz GA, et al.: Multivitamin use, folate and colon cancer in women in the nurses‘ health study. Ann Intern Med 1998; 129: 517-24


    39.Gnauck R, Macrae FA, Fleisher M: How to perform the fecal occult blood test. CA Cancer J Clin 1984; 34: 134-47


    40.Greenberg ER, Baron JA: Aspirin and other nonsteroid anti-inflammatory drugs as cancer-preventive agents. IARC Sci Publ 1996; 139: 91-8


    41.Greenstein AJ, Sachar DB, Smith H, Janowitz HD, Aufses AH: A comparison of cancer risk in Crohn‘s disease and ulcerative colitis. Cancer 1981; 48: 2742-5


    42.Guillem JG, Bastar AL, Ng J, Huhn JL, Cohen AM: Clustering of colorectal cancer in families of probands under 40 years of age. Dis Colon Rectum 1996; 39: 1004-7


    43.Guillem JG, Forde KA, Treat MR, et al.: Colonoscopic screening for neoplasms in asymptomatic first-degree relatives of colon cancer patients. A controlled, prospective study. Dis Colon Rectum 1992; 35: 523-9


    44.Gullberg K, Stahlberg D, Liljequist T, et al.: Neoplastic transformation of the pelvic pouch mucosa in patients with ulcerative colitis. Gastroenterology 1997; 112: 1487-92


    45.Gupta RA, DuBois RN: Aspirin, NSAIDS, and colon cancer prevention: mechanisms? Gastroenterology 1998; 114: 1095-8


    46.Gyde SN, Prior P, Allan RN, et al.: Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centers. Gut 1988; 29: 206-17


    47.Hall NR, Bishop DT, Stephensons BM, Finan PJ: Hereditary susceptibility to colorectal cancer. Relatives of early onset cases are particulary at risk. Dis Colon Rectum 1996; 39: 739-43


    48.Hardcastle JD, Thomas WM, Chamberlain J, et al.: Randomised, controlled trial of faecal occult blood screening for colorectal cancer. Results for first 107.349 subjects. Lancet 1989; I: 1160-4


    49.Hart AR, Kudo S, Mackay EH, Mayberry JF, Atkin WS: Flat adenomas exist in asymptomatic people: important implications for colorectal cancer screening programmes. Gut 1998; 43: 229-31


    50.Heilbrun LK, Nomura A, Hankin JH, Stemmermann GN: Diet and colorectal cancer with special reference to fiber intake. Int J Cancer 1989; 44: 1-6


    51.Herbay A, Herfarth C, Otto HF: Cancer and dysplasia in ulcerative colitis: a histologic study of 301 surgical specimen. Z Gastroenterol 1994; 32: 382-8


    52.Herfarth C, Heuschen G, Heuschen UA: Die maligne Entartung im Verlauf der Colitis ulcerosa und ihre chirurgischen Implikationen. Chirurg 1998; 69: 1020-7


    53.Heuschen G, Heuschen UA, Herfarth C: Primär sklerosierende Cholangitis - Colitis ulcerosa assoziierte Erkrankung mit chirurgischen Konsequenzen. Chirurg 1998; 69: 1028-34


    54.Hunt LM, Rooney PS, Hardcastle JD, Armitage NC: Endoscopic screening of relatives of patients with colorectal cancer. Gut 1998; 42: 71-5


    55.Jacobs DR Jr, Marquart L, Slavin J, Kushi LH: Whole-grain intake and cancer: an expanded review and meta-analysis. Nutr Cancer 1998; 30: 85-96


    56.Jass JR, Sobin LH: Histological typing of colorectal tumours. 2nd ed. WHO International Histological Classification of Tumours. Berlin, Heidelberg, New York, Tokyo: Springer, 1989


    57.Karita M, Cantero D, Okita K: Endoscopic diagnosis and resection treatment for flat adenoma with severe dysplasia. Am J Gastroenterol 1993; 88: 1421-3


    58.Karlen P, Kornfeld D, Brostrom O, Lofberg R, Persson PG, Ekbom A: Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study. Gut 1998; 42: 711-4


    59.Karnes WE: Epidemiology and etiology of sporadic colorectal adenocarcinoma. Current opinion in Gastroenterology 1994; 10: 19-26


    60.Kewenter J, Bjork S, Haglind E, Smith L, Svanvik J, Ahren C: Screening and rescreening for colorectal cancer. A controlled trial of fecal occult blood testing in 27.700 subjects. Cancer 1988; 62: 645-51


    61.Kornbluth A, Sachar DB: Ulcerative colitis practice guidelines in adults. American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 1997; 92: 204-11


    62.Kronborg O, Fenger C, Sondergaard O, Pedersen KM, Olsen J: Initial mass screening for colorectal cancer with fecal occult blood test. A prospective randomized study at Funen in Denmark. Scand J Gastroenterology 1987; 22: 677-86


    63.Kudo S, Kashida H, Nakajima T, Tamura S, Nakajo K: Endoscopic diagnosis and treatment of early colorectal cancer. World J Surg 1997; 21: 694-701


    64.Kudo S, Kashida H, Tamura S, Nakajima T: The problem of “flat” colonic adenoma. Gastrointest Endosc Clin N Am 1997; 7: 87-98


    65.Kudo S, Tamura S, Hirota S, et al.: The problem of de novo colorectal carcinoma. Eur J Cancer 1995; 31A: 1118-20


    66.Kudo S, Tamura S, Nakajima T, Yamano H, Kusaka H, Watanabe H: Diagnosis of colorectal tumorous lesions by magnifying endoscopy. Gastrointest Endosc 1996; 44: 8-14


    67.Kune GA, Kune S, Watson LF: The role of heredity in the etiology of large bowel cancer: data from the Melbourne Colorectal Cancer Study. World J Surg 1989; 13: 124-9


    68.Kune S, Kune GA, Watson LF: Case-control study of alcoholic beverages as etiological factors: the Melbourne Colorectal Cancer Study. Nutr Cancer 1987; 9: 43-56


    69.Langholz E, Munkholm P, Davidsen M, Binder V: Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology 1992; 103: 1444-51


    70.Lashner BA, Provencher KS, Seidner DL, Knesebeck A, Brzezinski A: The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis. Gastroenterology 1997; 112: 29-32


    71.Loftus EV, Sandborn WJ, Tremaine WJ, et al.: Risk of colorectal neoplasia in patients with primary sclerosing cholangitis. Gastroenterology 1996; 110: 432-40


    72.Lyon JL, Mahoney AW, West DW, et al.: Energy intake: its relationship to colon cancer risk. J Natl Cancer Inst 1987; 78: 853-61


    73.Macrae FA: Fat and calories in colon and breast cancer: from animal studies to controlled clinical trials. Prev Med 1993; 22: 750-66


    74.Mallory SB: Cowden syndrome (multiple hamartoma syndrome). Dermatol Clin 1995; 13: 27-31


    75.Mandel JS, Bond JH, Church TR, et al.: Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993; 328: 1365-71


    76.Marchesa P, Lashner BA, Lavery IC, et al.: The risk of cancer and dysplasia among ulcerative colitis patiens with primary sclerosing cholangitis. Am J Gastroenterol 1997; 92: 1285-8


    77.Markowitz AJ, Winawer SJ: Management of colorectal polyps. CA Cancer J Clin 1997; 47: 93-112


    78.Meagher AP, Stuart M: Colonoscopy in patients with a family history of colorectal cancer. Dis Colon Rectum 1992; 35: 315-21


    79.Muller AD, Sonnenberg A: Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case-control study of 32,702 veterans. Ann Intern Med 1995; 123: 904-10


    80.Muller AD, Sonnenberg A: Protection by endoscopy against death from colorectal cancer. A case-control study among veterans. Arch Intern Med 1995; 155: 1741-8


    81.Netzer P, Forster C, Biral R, et al.: Risk factor assessment of endoscopically removed malignant colorectal polyps. Gut 1998; 43: 669-74


    82.Neugut AI, Garbowski GC, Lee WC, et al.: Dietary risk factors for the incidence and recurrence of colorectal adenomatous polyps. A case-control study. Ann Intern Med 1993; 118: 91-5


    83.Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM: Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992; 84: 1572-5


    84.Nuako KW, Ahlquist DA, Sanborn WJ, Mahoney DW, Siems DM, Zinsmeister AR: Primary sclerosing cholangitis and colorectal carcinoma in patients with ulcerative colitis: a case-control study. Cancer 1998; 82: 822-6


    85.Otchy DP, Ransohoff DF, Wolff BG, et al.: Metachronous colon cancer in persons who have had a large adenomatous polyp. Am J Gastroenterol 1996; 91: 448-54


    86.Papadopoulos N, Lindblom A: Molecular basis of HNPCC: mutations of MMR genes. Hum Mut 1997; 10: 89-99


    87.Pariente A, Milan C, Lafon J, Faivre J: Colonoscopic screening in first-degree relatives of patients with ‚sporadic‘ colorectal cancer: a case-control study. The Asssociation Nationale des Gastroenterologues des Hospitaux and Registre Bouguignon des Cancer Digestifs (INSERM CRI 9505). Gastroenterology 1998; 115: 7-12.


    88.Persson PG, Karlen P, Bernell O, et al.: Crohn‘s disease and cancer: a population-based cohort study. Gastroenterology 1994; 107: 1675-9


    89.Pinczowski D, Ekbom A, Baron J, Yuen J, Adami HO: Risk factors for colorectal cancer in patients with ulcerative colitis. a case-control study. Gastroenterology 1994; 107: 117-20


    90.Potter JD, McMichael AJ: Diet and cancer of the colon and rectum: a case-control study. J Natl Cancer Inst 1986; 76: 557-569


    91.Pritchard RS, Baron JA, Gerhardsson de Verdier M: Dietary calcium, vitamin D and the risk of colorectal cancer in Stockholm, Sweden. Cancer Epidemiol Biomarkers Prev 1996; 5: 897-900


    92.Provenzale D, Kowdley KV, Arora S, Wong JB: Prophylactic colectomy or suveillance for chronic ulcerative colitis? A decision analysis. Gastroenterology 1995; 109: 1188-96


    93.Read TE, Read JD, Butterly LF: Importance of adenomas 5 mm or less in diameter that are detected by sigmoidoscopy. N Engl J Med 1997; 336: 8-12


    94.Rex DK, Cutler CS, Lemmel GT, et al.: Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology 1997; 112: 24-8


    95.Rex DK, Rahmani EY, Haseman JH, Lemmel GT, Kaster S, Buckley JS: Relative sensitivity of colonoscopy and barium enema for detection of colorectal cancer in clinical practice. Gastroenterology 1997; 112: 17-23


    96.Roberts-Thomson IC, Ryan P, Khoo KK, Hart WJ, McMichael AJ, Butler RN: Diet, acetylator phenotype, and risk of colorectal neoplasia. Lancet 1996; 347: 1372-4


    97.Rodriguez-Bigas MA, Boland CR, Hamilton SR, et al.: A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst 1997; 89: 175-62.


    98.Rosenberg L, Louik C, Shapiro S: Nonsteroidal antiinflammatory drug use and reduced risk of large bowel carcinoma. Cancer 1998; 82: 2326-9.


    99.Rozen P, Fireman Z, Figer A, Legum C, Ron E, Lynch HT: Family history of colorectal cancer as a marker of potential malignancy within a screening programm. Cancer 1987; 60: 248-54


    100.Schoen RE, Corle D, Cranston L, et al.: Is colonoscopy needed for the nonadvanced adenoma found on sigmoidoscopy? The Polyp Prevention Trial. Gastroenterology 1998; 115: 533-41


    101.Selbmann HK: Entwicklung von Leitlinien in der Medizin - Kunst oder Können? Chirurg 1996; 35: 61-5


    102.Selby JV, Friedman GD, Quesenberry CP, Weiss NS: A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992; 326: 653-7


    103.Shibata A, Paganini-Hill A, Ross RK, Henderson BE: Intake of vegetables, fruits, beta-carotene, vitamin C and vitamin supplements and cancer incidence among the elderly: a prospective study. Br J Cancer 1992; 66: 673-9


    104.Slattery ML, Boucher KM, Caan BJ, Potter JD, Ma KN: Eating patterns and risk of colon cancer. Am J Epidemiol 1998; 148: 4-16


    105.Slattery ML, Schumacher MC, Smith KR, West DW, Abd-Elghany N: Physical activity, diet, and risk of colon cancer in Utah. Am J Epidermiol 1988; 128: 989-99


    106.Sondergaard JO, Bulow S, Lynge E: Cancer incidence among parents of patients with colorectal cancer. Int J Cancer 1991; 47: 202-6


    107.Soravia C, Berk T, Madlensky L, et al.: Genotype-phenotype correlations in attenuated adenomatous polyposis coli. Am J Hum Genet 1998; 62:1290-1301


    108.St John DJ, McDermott FT, Hopper JL, Debney EA, Johnson WR, Hughes ES: Cancer risk in relatives of patients with common colorectal cancer. Ann Int Med 1993; 118: 785-90


    109.Stahelin HB, Gey KF, Eichholzer M, Ludin E: Beta-carotene and cancer prevention: the Basel Study. Am J Clin Nutr 1991; 53(1 Suppl): 265S-269S


    110.Statistisches Bundesamt: Statistisches Jahrbuch 1998. Stuttgart: Metzler-Poeschel, 1998


    111.Stefansson T, Ekborm A, Sparen P, Pahlman L: Cancers among patients diagnosed as having diverticular disease of the colon. Eur J Surg 1995; 161: 755-60


    112.Towler B, Irwig L, Glasziou P, Kewenter J, Weller D, Silagy C: A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult. BMJ 1998; 317: 559-65


    113.van Stolck RU, Beck GJ, Baron JA, Haile R, Summers R: Adenoma characteristics at first colonoscopy as predictors of adenoma recurrence and characteristics at follow-up. The Polyp Prevention Study Group. Gastroenterology 1998; 115: 13-8


    114.Vasen HF, Bülow S, Myrhøj T, et al.: Decision analysis in the management of duodenal adenomatosis in familial adenomatous polyposis. Gut 1997; 40: 716-9


    115.Vasen HF, Mecklin JP, Khan PM, Lynch HT: The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 1991; 34: 424-5


    116.Vider BZ, Zimber A, Chastre E, et al.: Evidence for the involvement of the Wnt 2 gene in human colorectal cancer. Oncogene 1996; 12: 153-8


    117.Volk EE, Goldblum JR, Petras RE, Carey WD, Fazio VW: Management and outcome of patients with invasive carcinoma arising in colorectal polyps. Gastroenterology 1995; 109: 1801-7


    118.Wallace MB, Kemp JA, Trnka YM, Donovan JM, Farraye FA: Is colonoscopy indicated for small adenomas found by screening flexible sigmoidoscopy? Ann Intern Med 1998; 129: 273-8


    119.West DW, Slattery ML, Robinson LM, et al.: Dietary intake and colon cancer: sex- and anatomic site-specific associations. Am J Epidermiol 1989; 130: 883-94


    120.Willett WC, Stampfer MJ, Colditz GA, Rosner BA, Speizer FE: Relation of meat, fat and fiber intake to the risk of colon cancer in a prospective study among women. N Engl J Med 1990; 323: 1664-72


    121.Winawer SJ: Follow-up after polypectomy. World J Surg 1991; 15: 25-8


    122.Winawer SJ: Appropriate intervals for surveillance. Gastrointest Endosc 1999; 49: S63-6


    123.Winawer SJ, Flehinger BJ, Schottenfeld D, Miller DG: Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. J Natl Cancer Inst 1993; 85: 1311-8


    124.Winawer SJ, Fletcher RH, Miller L, et al.: Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997; 112: 594-642


    125.Winawer SJ, O‘Brien MJ, Waye JD, et al.: Risk and surveillance of individuals with colorectal polyps. WHO Collaborating Centre for the Prevention of Colorectal Cancer. Bull World Health Organ 1990; 68: 789-95


    126.Winawer SJ, St John DJ, Bond JH, et al.: Guidelines for the prevention of colorectal cancer: update based on new data. World Health Organization Collaborating Center for the Prevention of Colorectal Cancer. Z Gastroenterol 1995; 33: 574-6


    127.Winawer SJ, St John DJ, Bond JH, et al.: Prevention of colorectal cancer: guidelines based on new data. WHO Collaborating Center for the Prevention of Colorectal Cancer. Bull World Health Organ 1995; 73: 7-10


    128.Winawer SJ, St John DJ, Bond JH, et al.: Aktualisierte WHO-Richtlinien zur Früherkennung des koloretalen Karzinoms. Leber Magen Darm 1996; 26: 139-43


    129.Winawer SJ, Zauber AG, Gerdes H, et al.: Risk of colorectal cancer in the families of patients with adenomatous polyps. National Polyp Study Workgroup. N Engl J Med 1996; 334: 82-7


    130.Winawer SJ, Zauber AG, Ho MN, et al.: Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 1993; 329: 1977-81


    131.Winawer SJ, Zauber AG, O‘Brien MJ, et al.: Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. N Engl J Med 1993; 328: 901-6


    132.Winde G, Schmid KW, Schlegel W, Fischer R, Osswald H, Bunte H: Complete reversion and prevention of rectal adenomas in colectomized patients with familial adenomatous polyposis by rectal low-dose sulindac maintenance treatment. Advantages of low-dose nonsteroidal anti-inflammatory drug regimen in reversing adenomas exceeding 33 months. Dis Colon Rectum 1995; 38: 813-30


    133.Winther JF, Dreyer L, Overvad K, Tjonneland A, Gerhardsson de Verdier M: Avoidable cancers in the Nordic countries. Diet, obesity and low physical activity. APMIS Suppl. 1997; 76: 100-19


    134.Woolf SH: Practice guidelines, a new reality in medicine. II. Methods of developing guidelines. Arch Intern Med 1992; 152: 946-52


    135.World Cancer Research Fund, American Institute for Cancer Research. Food, nutrition and the prevention of cancer: a global perspective. 1997


    136.Zarchy TM, Ershoff D: Do characteristics of adenomas on flexible sigmoidoscopy predict advanced lesions on baseline colonoscopy? Gastroenterology 1994; 106: 1501-4


    137.Zauber AG, Winawer SJ: Initial management and follow-up surveillance of patients with colorectal adenomas. Gastroenterol Clin North Am 1997; 26: 85-101





[Start Leitlinien] [» Asthma] [» Kopfschmerzen] [» Hypertonie] [» Otitis media] [» Gallensteine] [» Herzinsuffizienz] [» Demenz] [» Harnwegsinfekt] [» KR-Karzinom] [Algorithmus] [Volltext] [Referenzen] [Patientenleitlinie] [Impressum / ©] [» Dekubitus] [Ihre Meinung?] [Interne Infos]

Eine Aktualisierung dieser Leitlinien ist nicht geplant (Stand September 2007)



® Medizinisches Wissensnetzwerk der Universität Witten/Herdecke Patienten...